Geron Corporation (GERN)

Geron Market Cap

Geron has a market cap or net worth of $808.32 million as of June 18, 2026. Its market cap has decreased by -17.59% in one year.

• Market Cap: 808.32M
• Enterprise Value: 591.30M
• 1-Year Change: -17.59%
• Ranking: #2762
• Category: Small-Cap
• Stock Price: $1.26

Market Cap Chart

Since December 1, 1998, Geron's market cap has increased from $159.40M to $808.32M, an increase of 407.10%. That is a compound annual growth rate of 6.07%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2026	808.30M	-4.07%
Dec 31, 2025	842.60M	-60.62%
Dec 31, 2024	2.14B	86.74%
Dec 29, 2023	1.15B	24.20%
Dec 30, 2022	922.60M	134.88%
Dec 31, 2021	392.80M	-20.44%
Dec 31, 2020	493.70M	81.71%
Dec 31, 2019	271.70M	45.84%
Dec 31, 2018	186.30M	-35.00%
Dec 29, 2017	286.60M	-12.99%
Dec 30, 2016	329.40M	-56.99%
Dec 31, 2015	765.80M	49.89%
Dec 31, 2014	510.90M	-16.42%
Dec 31, 2013	611.30M	231.51%
Dec 31, 2012	184.40M	-5.24%
Dec 30, 2011	194.60M	-63.43%
Dec 31, 2010	532.20M	4.66%
Dec 31, 2009	508.50M	37.54%
Dec 31, 2008	369.70M	-13.62%
Dec 31, 2007	428.00M	-26.52%
Dec 29, 2006	582.50M	4.37%
Dec 30, 2005	558.10M	53.45%
Dec 31, 2004	363.70M	-6.72%
Dec 31, 2003	389.90M	337.60%
Dec 31, 2002	89.10M	-53.52%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 18, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jun 20, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Theravance Biopharma	854.75M
Replimune Group	841.41M
Olema Pharmaceuticals	830.67M
Solid Biosciences	820.09M
Annexon	802.83M
Alto Neuroscience	798.04M
Vor Biopharma	785.15M
Design Therapeutics	776.96M